QA: Checkpoint Therapeutics Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001651407_2020_Checkpoint_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001651407, Checkpoint Therapeutics Inc

  xvar xval
0 AssetsCurrent 26,966,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 8,119,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,476,100
9 ResearchAndDevelopmentExpense 23,465,003
10 remainder_Expenses 0
11 remainder_Revenues 2,506,352
12 remainder_NetIncome 180,490
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 26,966,000
1 Liabilities 8,119,000
2 Expenses 30,941,103
3 Revenues 2,506,352
4 StockholdersEquity 18,847,000
5 NetIncome -28,254,261
6 ComprehensiveNetIncome -28,254,261
7 BaseVar 34,356,472
8 EconomicCapitalRatiobeforeLimitedLiability 0.731
9 EconomicCapitalRatio 2.08

Edgar->Model Mapping

Feature Distribution

Change over Time